PubMed:32513289 / 0-115
Annnotations
LitCovid-OGER-BB
{"project":"LitCovid-OGER-BB","denotations":[{"id":"T1","span":{"begin":4,"end":14},"obj":"SP_7"},{"id":"T2","span":{"begin":107,"end":115},"obj":"SP_7"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":4,"end":12},"obj":"Disease"},{"id":"T2","span":{"begin":107,"end":115},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19"}